Co-Authors
This is a "connection" page, showing publications co-authored by Gian Marseglia and Amelia Licari.
Connection Strength
10.061
-
What are the considerations for treating pediatric asthma during the COVID-19 pandemic? Expert Opin Pharmacother. 2021 04; 22(6):651-653.
Score: 0.929
-
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares. Allergy. 2020 09; 75(9):2402-2405.
Score: 0.884
-
Immunomodulation in Pediatric Asthma. Front Pediatr. 2019; 7:289.
Score: 0.832
-
Food Allergies: Current and Future Treatments. Medicina (Kaunas). 2019 May 01; 55(5).
Score: 0.821
-
Current and future challenges in pediatric severe asthma. Curr Med Res Opin. 2018 05; 34(5):943-944.
Score: 0.758
-
The Nose and the Lung: United Airway Disease? Front Pediatr. 2017; 5:44.
Score: 0.707
-
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases. Curr Respir Med Rev. 2017 Mar; 13(1):22-29.
Score: 0.706
-
Novel therapeutic approaches targeting endotypes of severe airway disease. Expert Rev Respir Med. 2021 10; 15(10):1303-1316.
Score: 0.237
-
Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review. Acta Paediatr. 2021 09; 110(9):2529-2535.
Score: 0.237
-
Additional Concerns Regarding Children With Coronavirus Disease 2019-Reply. JAMA Pediatr. 2020 12 01; 174(12):1218-1219.
Score: 0.229
-
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019. Allergy Asthma Proc. 2020 11 01; 41(6):e80-e82.
Score: 0.228
-
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020 Sep 01; 174(9):882-889.
Score: 0.225
-
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020 09; 125(3):361-362.
Score: 0.225
-
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment. Behav Sci (Basel). 2019 Jul 13; 9(7).
Score: 0.208
-
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management. Eur Ann Allergy Clin Immunol. 2019 07; 51(4):190-192.
Score: 0.208
-
Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology. Expert Rev Vaccines. 2019 05; 18(5):523-545.
Score: 0.205
-
Asthma control in children and adolescents: a study in clinical practice. J Asthma. 2020 06; 57(6):645-647.
Score: 0.205
-
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. Respir Med. 2019 05; 151:118-120.
Score: 0.204
-
Vitamin D3 in children with allergic asthma in clinical practice. Pediatr Pulmonol. 2019 03; 54(3):225-227.
Score: 0.201
-
Increased Total Serum Immunoglobulin E in Children Developing Mycoplasma pneumoniae-related Extra-pulmonary Diseases. Iran J Allergy Asthma Immunol. 2018 Oct 09; 17(5):490-496.
Score: 0.197
-
Clinical use of basophil activation test in drug, food and hymenoptera venom allergies. Minerva Pediatr. 2019 Apr; 71(2):209-217.
Score: 0.197
-
Pediatric rhinosinusitis and asthma. Respir Med. 2018 08; 141:94-99.
Score: 0.193
-
New approaches for identifying and testing potential new anti-asthma agents. Expert Opin Drug Discov. 2018 01; 13(1):51-63.
Score: 0.185
-
Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management. World J Methodol. 2016 Dec 26; 6(4):200-213.
Score: 0.174
-
The discovery and development of omalizumab for the treatment of asthma. Expert Opin Drug Discov. 2015; 10(9):1033-42.
Score: 0.156
-
COVID-19 in Italian children and adolescents: The role of allergy and asthma. Allergy Asthma Proc. 2021 05 01; 42(3):e101-e102.
Score: 0.059
-
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
Score: 0.058
-
Digital health interventions in children with asthma. Clin Exp Allergy. 2021 02; 51(2):212-220.
Score: 0.057
-
Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician. Pediatr Allergy Immunol. 2020 11; 31 Suppl 26:92-95.
Score: 0.057
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057
-
SARS-CoV-2 infection in pediatric population. Acta Biomed. 2020 09 15; 91(11-S):e2020003.
Score: 0.056
-
Timely adaptation of a Pediatric Unit to COVID-19 emergency in Northern Italy: the experience of Fondazione IRCCS Policlinico San Matteo in Pavia. Acta Biomed. 2020 09 15; 91(11-S):e2020004.
Score: 0.056
-
Special Issues for Coronavirus Disease 2019 in Children and Adolescents. Obesity (Silver Spring). 2020 08; 28(8):1369.
Score: 0.056
-
Novel therapeutic targets for allergic airway disease in children. Drugs Context. 2019; 8:212590.
Score: 0.052
-
Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study. Cytotherapy. 2019 09; 21(9):958-972.
Score: 0.052
-
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy. Allergol Immunopathol (Madr). 2019 May - Jun; 47(3):309-310.
Score: 0.050
-
Transient symptomatic zinc deficiency in a breast-fed African infant: case report and literature review. Int J Dermatol. 2019 Aug; 58(8):963-965.
Score: 0.049
-
Immunotherapy and Asthma in Children. Front Pediatr. 2018; 6:231.
Score: 0.049